• Agenda
    • Programs
    • Breakout Discussions
    • Short Courses
    • Plenary Keynotes
    • Speaker Biographies
    • Training Seminars
    • Attendees
    • Archives
  • Sponsor/Exhibitor
    • Attendee Demographics + Event Features
    • Sponsorship Opportunities
    • Current Sponsors
    • Current Exhibitors/Floorplan
    • Exhibit Contract
    • Exhibit Services Schedule
    • Exhibitor Prospectus
    • Lead Generation Opportunities
    • FAQs
    • Sponsor & Exhibitor Portal
  • Downloads
    • Downloads
    • Interviews
  • Travel
  • Posters
    • Poster Information
    • Poster Titles
  • 1-on-1 Networking
  • Register
    • Event Registration
    • Student Registration
    • Press
sponsorship-exhibit-banner
Demographics Sponsors Opportunities Exhibits Lead Gen FAQ

Sponsors

Premier Sponsors

  • AbCellera
  • Ablexis Alivamab_stacked
  • Charles-River
  • Eurofins_Discovery
  • IBM_WatsonHealth_1
  • Integral
  • OmniAb Ligand_Pharmaceuticals

Corporate Sponsors

  • AbCheck
  • Biosensing_Instrument
  • CollaborativeDrugDiscovery_horizontal
  • Cellecta
  • Chemical_Computing_Group
  • CILcare
  • domainex-logo
  • DomainTherapeutics
  • GenScript-CRO
  • Isogenica
  • JubilantBiosys
  • Life-Sensors_tagline
  • Metabolon
  • Multispan-light
  • Reaction Bio
  • Retrogenix
  • Schrodinger
  • SGI-DNA-SyntheticGenomics
  • Sino-Biological
  • Syngene
  • TetraGenetics
  • TWIST-Bioscience
  • Vaccinex
  • ZoBio

Corporate Support Sponsors

  •  CISBIO_tagline
  • Immunoprecise

Outlook YouTube Facebook LinkedIn Twitter
#BostonDOT19
Final Agenda Now Available

2019 Programs

September 17 - 18

Target Identification and Validation
Lead Generation Strategies
Emerging Ubiquitin and Autophagy Targets
Targeting NASH
Immuno-Oncology: Emerging Targets and Therapeutics NEW
Antibodies Against Membrane Protein Targets – Part 1
Antibody Forum – Part 1

September 18 - 19

RNA as a Drug Target NEW
Kinase Inhibitor Discovery
PROTACs and Targeted Protein Degradation NEW
Targeting Fibrosis NEW
GPCR-Based Drug Discovery
Antibodies Against Membrane Protein Targets – Part 2
Antibody Forum – Part 2

Premier Sponsors

AbCellera

Ablexis Alivamab_stacked

Charles-River

Eurofins

Integral

OmniAb Ligand_Pharmaceuticals

CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Genomics

Healthcare

IT & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers

Request Information

Privacy Policy